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Background: Projections on the future suggest a further rise in the prevalence of patients with 
COPD, and in COPD related morbidity, mortality, and health care costs worldwide. Given the 
substantial impact on the individual and on society, it is important to establish a care process 
that maximizes outcomes in relation to the costs and efforts made. In an attempt to bridge this 
gap, we set out to develop an evidence-based model of integrated care for patients with COPD, 
named the COPDnet integrated care model.
Purpose: The current study protocol sets out to 1) evaluate the feasibility of employing the 
COPDnet model in present real-life care within the context of the Dutch health care system, 
2) explore the potential health status benefits, and 3) analyze the costs of care of this model.
Patients and methods: In this prospective study, feasibility and health status changes will 
be evaluated with an experimental before and after study design. The costs of the diagnostic 
trajectory will be calculated according to a standard economic health care evaluation approach. 
Furthermore, the feasibility and cost of care studies will comprise both quantitative and qualita-
tive data collection. For the studies on the feasibility and change in health status, all new patients 
qualifying for shared care by primary and secondary care professionals according to the Dutch 
Standard of Care for COPD, and patients referred by their general practitioners to one of the 
COPDnet hospitals will be included. To evaluate the feasibility and costs of care, semi-structured 
interviews will be held with patients, hospital personnel, health care professionals in the affili-
ated primary care region, and hospital and primary care group managers.
Conclusions: The COPDnet integrated care model for COPD patients has been designed 
according to the current insights regarding effective care for patients with a chronic condition in 
general, and for patients with COPD in particular. It will be evaluated for its feasibility, potential 
health status benefits, and the costs of care of the diagnostic trajectory in secondary care.
Keywords: COPD, COPD management, integrated care, chronic care model, health status
Introduction
COPD is defined as a common, preventable, and treatable disease that is characterized 
by persistent respiratory symptoms and airflow limitation.1 Moreover, COPD is a 
complex and heterogeneous disease with highly variable clinical manifestations.2,3 
Even when COPD patients are in a relatively stable phase of their disease or only 
have mild-to-moderate airway obstruction, COPD often puts a significant burden of 
disease on those affected.2 The impact of COPD also places a high burden on health 
care resources, given the significant direct and indirect costs of care.4 Projections on 
the future suggest a further rise in the prevalence of patients with COPD, morbidity, 
mortality, and health care costs worldwide.5
Given the substantial impact on the individual and on society, it is important 
to establish a care process that maximizes outcomes in relation to the efforts and 
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costs made.6 There is evidence to suggest that COPD disease 
management programs, providing integrated holistic care in 
an integrated care process, have the potential to better both 
health outcomes and costs compared with single-dimensional 
medical approaches.7 A recent review shows that better 
outcomes may be achieved with an integrated disease 
management program of at least 3 months duration with a 
follow-up ranging from 3 to 24 months on disease-specific 
quality of life and exercise capacity, and also, a reduction in 
respiratory-related hospital admissions and hospital days per 
person.8 The clinical impression is, however, that integrated 
care models are, as yet, only in limited use in our present 
care delivery pathways. This was confirmed in a recently 
performed survey in five European Union countries, includ-
ing the Netherlands. In this paper, the authors concluded that 
COPD health care pathways are fragmented and care is not 
integrated properly.9
In an attempt to bridge this gap, we set out to develop 
an evidence-based model of integrated care for patients with 
COPD, named the COPDnet integrated care model.10 The 
COPDnet integrated care model has the ambition to innovate, 
simultaneously, both the content of care, ie applying a holistic 
approach, as well as the organization of care, ie, providing 
coherent, integrated care within the Dutch health care system. 
The use of such a model holds a promise to generate better 
outcomes of care for patients with COPD, as well as an 
overall reduction in the health care costs.11
As we acknowledge that it is a challenge to implement 
this highly complex COPDnet integrated care model,12 the 
current study protocol sets out 1) to evaluate the feasibility 
of employing the COPDnet model in present day real-life 
care within the context of the Dutch health care system, 
2) to explore the potential health status benefits from the 
patients’ perspective, and 3) to analyze the costs of care of 
this model.
Objectives of the study protocol
To realize the objectives of the current research project, 
a series of interrelated studies will be conducted with the 
following aims:
•	 To evaluate the feasibility of the implementation of the 
COPDnet integrated care model.
•	 To evaluate changes in health status over time in COPD 
patients who were offered care according to the COPDnet 
integrated care model.
•	 To evaluate the costs of care of the diagnostic trajectory 
in secondary care, as a component of the COPDnet inte-
grated care model.
The objective of this article is to present the rationale and 
the different methods of this prospective study.
Intervention
The COPDnet integrated care model describes a trans-
parent and highly standardized outpatient care process. 
Figure 1 represents a graphical overview of all elements of the 
COPDnet integrated care model, that is, a diagnostic trajec-
tory carried out in secondary care, a non-medical intervention 
program provided in primary care, and a pulmonary rehabilita-
tion service in tertiary care. The model also includes a quality 
management system based on patient-reported outcome mea-
surements (PROMs), and regional appointments pertaining to 
exacerbation management and palliative care. Principles of the 
model include the following: 1) an individual care plan based 
on an assessment of the individual determinants of the burden 
of disease, 2) which is carried out closely to the natural habitat 
of the patient, and 3) looks for opportunities to initiate behav-
ioral change, ie reinforcement of patients’ self-management 
capabilities. Full details of the COPDnet integrated care model 
can be found in a recently published article by Koolen et al.10
Methods and analyses
Study setting and design
The series of studies of this research project will be carried 
out in three hospitals and their affiliated primary care region, 
that is, the outpatient clinic of the Department of Pulmonary 
Diseases of Radboudumc (Nijmegen), Bernhoven Hospital 
(Uden), and Canisius Wilhelmina Hospital (Nijmegen).
In this prospective study, feasibility and health status 
changes will be evaluated with an experimental before and 
after study design. The costs of the diagnostic trajectory will 
be calculated according to a standard economic health care 
evaluation approach. Furthermore, the feasibility and cost of 
care studies will comprise both quantitative and qualitative 
data collection and analyses.
Study population
Patients
For the studies on the feasibility of the implementation of 
this COPDnet integrated care model and of the change in 
health status, patients will be included based on the following 
two criteria:
•	 New patients qualifying for shared care by primary and 
secondary care professionals according to the Dutch 
Standard of Care for COPD13
•	 Patients referred by their general practitioners (GPs) to the 
outpatient clinic of Radboudumc, Bernhoven Hospital, 
or Canisius Wilhelmina Hospital.
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Patients will be excluded if
•	 the patient is unable to complete questionnaires because 
of cognitive impairment and
•	 the patient is unable to speak or understand the Dutch 
language.
Health care professionals
To evaluate the feasibility and costs of care, the following 
health care professionals, providing care according to the 
COPDnet integrated care protocol, will be included in these 
studies:
•	 Primary care: GPs nurse practitioners, physiotherapists, 
dieticians, occupational therapists, and primary care 
group managers.
•	 Secondary care: pulmonary specialists, respiratory nurse 
specialists, pulmonary function technicians, medical 
secretaries, staff of the clinometric department, and 
hospital care group managers.
Outcomes
Feasibility
The feasibility of implementing the COPDnet integrated 
care model will be evaluated from three different perspec-
tives, that is, patient perspective, health care perspective, 
and organizational perspective, applying both quantitative 
and qualitative methods.
Quantitative evaluation
The following questionnaires will be used for the evaluation 
of the patient outcomes: the Consumer Quality Index Asthma 
and COPD14 and the Patients Assessment Chronic Illness 
Care15; to evaluate the health care professional perspective, 
the Assessment of Chronic Illness Care,16 the Clinician 
Support for Patient Activation Measure,17 and the Assess-
ment of Primary Care Recourses and Supports for Chronic 
Disease Self-Management;18 and finally, for the evaluation of 
the organizational perspective, the Care Process Self Evalu-
ation Tool will be applied.19
Qualitative evaluation
First of all, two authors (EHK and AJvH) will develop 
semi-structured interview guides, which should enhance the 
feasibility of using the COPDnet model in contemporary 
health care within the context of the Dutch health care system. 
The semi-structured interview guides will be tailored specifi-
cally to patients, hospital personnel, health care professionals 
in the affiliated primary care region, and hospital and primary 
care group managers. 
Figure 1 Graphical overview of the COPDnet integrated care model.
Abbreviations: Dt, diagnostic trajectory; GP, general practitioner; PrOMs, patient-reported outcome measurements.
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The patients will be selected based on the purposive 
sampling from the three COPDnet hospitals. We will seek a 
varied sample of patients based on age, sex, and burden of 
disease. The respiratory nurse specialists will invite these 
patients for participation in one of the interviews after they 
have completed the full trajectory of the COPDnet integrated 
care model. EHK will invite the professionals by telephone or 
e-mail. All participants will receive written information about 
the purpose and procedure of the interviews and they will be 
asked to confirm their participation by e-mail or telephone. 
Moreover, EHK will use the interview guides to conduct the 
semi-structured interviews, either by telephone or face-to-
face, after obtaining written informed consent.
Analysis of the patient perspective, health care profes-
sional perspective, and organizational perspective ques-
tionnaires, patient health records and the semi-structured 
interviews will be carried out between 12 and 36 months 
after the implementation of the COPDnet model in the three 
participating hospitals.
Health status
An analysis will be made of the potential improvements 
in health status through measuring changes in health 
status in patients enrolled in the COPDnet model, using 
widely accepted and validated PROMs. Primary outcome 
measure will be the Clinical COPD Questionnaire (CCQ). 
The results of the health status of enrolled patients at 
baseline, and at 6 months after the diagnostic trajectory in 
the COPDnet hospitals, will be compared.20 The CCQ is 
a self-administrated questionnaire and the psychometric 
properties are well documented.20 In addition to the primary 
outcomes, the following secondary outcome measurements 
will be systematically registered in the COPDnet hospitals: 
the Patient Activation Measure,21,22 the Nijmegen Clinical 
Screening Instrument,23,24 and physical activity measured 
with the Marshall Questionnaire.25 All data will be collected 
at baseline during the first visit at the hospital, at discharge 
after completion of the diagnostic trajectory of the COPDnet 
model and, finally, after 6-month follow-up. Also, patient 
characteristics and the following health status characteristics 
will be registered at baseline: the medication prescribed in 
primary care, comorbidities, smoking behavior, pulmonary 
function, blood gas analysis, 6-minute walking distance, 
physical activity measured with an activity monitor, medical 
diagnosis, and the classification of the burden of disease.
Costs of care
Costs of care will be analyzed on the basis of completed and 
registered care activities performed during the diagnostic 
trajectory in the participating hospitals of the COPDnet 
model, complying with the principles of Time-Driven 
Activity-Based Costing (TDABC) in value-based health 
care.26 TDABC requires the estimation of two parameters: 
the costs per time required to supply resources to the activi-
ties and the time required to perform activities in service 
deliveries.26 We will use the seven-step approach to the appli-
cation of the TDABC in our health care setting.27 By using 
the TDABC model, we will be able to understand the cost of 
care delivery and control costs.28 We will develop TDABC 
models for all COPDnet hospitals, in which direct costs and 
indirect costs for delivering the diagnostic trajectory are 
taken into account.
Cost mapping will be performed on 1) calculation of the 
total (internal) costs of the COPDnet model on the basis of 
factual delivery of care activities and time spent to carry 
out these activities and 2) comparing the (internal) costs 
of the diagnostic trajectory with the reimbursement fees of 
the health insurance companies. Data source for cost map-
ping is the Hospital Information System of the participating 
hospitals.
TDABC models have been using different methods with 
respect to the time required to perform activities, which 
may result in different costs of patient care.28 Therefore, 
our TDABC models will be developed on the basis of three 
methods. First of all, we will evaluate the direct and indirect 
(non-) patient-related time through an objective measurement 
of time. Therefore, we will measure the time of each step in 
the diagnostic trajectory by using a stopwatch. Second, we 
will evaluate the direct and indirect (non-) patient-related 
time subjectively, by interviewing all the participating health 
care professionals. Third, we will interview the hospital care 
group managers, so that they may estimate the invested time 
of each step in the diagnostic trajectory in the secondary 
care setting. Differences and similarities between these three 
approaches will be evaluated. Finally, we will compare the 
TDABC models with the average costs of usual care, which 
was provided before the introduction of the COPDnet model, 
based on health care records. 
Qualitative evaluation
EHK and AvtH will also develop the semi-structured inter-
view guides for the participating health care professionals 
and hospital care group managers, in which the focus will 
be on an estimate of the time that the professionals have to 
invest to meet the requirements of the COPDnet model. All 
the participating health care professionals and hospital care 
group managers from the three COPDnet hospitals, who work 
according to the model, will be invited. EHK will invite the 
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professionals by telephone or e-mail, and if they want to 
participate, they will receive written information about the 
purpose and procedure of the interview. EHK will use the 
interview guides to conduct the semi-structured interviews, 
either by telephone or face-to-face, after obtaining written 
informed consent.
Sample size
Feasibility
On each location, semi-structured interviews will be held 
with patients, clinicians, and managers. We anticipate on 
including five patients on each location – dependent on data 
saturation. Also, on each location, two pulmonary specialists, 
two respiratory nurses, and, of each discipline, two allied 
health care professionals will be invited to participate in 
the interviews. The to be interviewed pulmonary specialists 
and respiratory nurse specialists include all health care pro-
fessionals, actually providing care following the COPDnet 
model in the three participating hospitals. Finally, a conve-
nient sample of hospital and primary care group managers 
will be interviewed on what working with the COPDnet 
model means from an organizational perspective and how 
this affects feasibility. 
Health status
The sample size for the secondary objective is estimated 
using G-power with an a priori paired t-test, based on an 
estimated difference between two dependent means. A total 
of 199 patients are required to detect a small effect size of 
0.2 on the CCQ, with a significance of 5% and a power of 
80%. However, anticipating a dropout rate of 25%, we will 
include 250 patients.
Costs of care
To evaluate the time invested, semi-structured interviews 
will be held with two pulmonary specialists, two respiratory 
nurses, one pulmonary function technician, one medical 
secretary, and one hospital care group manager, on each 
location.
recruitment
All patients, qualifying for shared care in primary and 
secondary care settings (according to the Dutch Standard 
of Care for COPD13) and who are referred by their GP 
to secondary care will be automatically enrolled into the 
COPDnet model, in the outpatient clinic of the Radboudumc 
(Nijmegen), in the Bernhoven Hospital (Uden), or in the 
Canisius Wilhelmina Hospital (Nijmegen). Within these 
three hospitals, the COPDnet integrated care model has 
been accepted as the new standard care pathway for all new 
patients with COPD. All patients will be examined accord-
ing to the new standard patient care pathway in one of the 
COPDnet hospitals mentioned above. Furthermore, patients 
will not be exposed to extra questionnaires, tests, or site 
visits. Only a minority of the purposively selected patients 
(10–15/200=5%–8%), and all of the participating COPDnet 
health care professionals, will be asked to participate, volun-
tarily, in a semi-structured interview. Therefore, patients and 
health care professionals in this study will not be exposed to 
any additional health-related risk. Patients will be informed 
about the study by the way of a patient information form. 
All patients receiving usual care, according to the COPDnet 
model, will be included in these studies and will be excluded 
only when they say they are unwilling to participate.
Data management
All study data will be handled confidentially. The handling 
of the personal data will be fully compliant with the Dutch 
Personal Data Protection Act (de Wet Bescherming Persoon-
sgegevens). Study data will be kept for 15 years.
Statistical analyses
Quantitative analyses
Descriptive statistics, including means, SD, frequencies, 
medians, and interquartile ranges will be used to summarize 
our collected data. Handling missing data will be carried out 
according to the guidelines of the different questionnaires.
To evaluate the feasibility of the COPDnet model, a 
two-tailed paired sample t-test or Wilcoxon signed rank test 
will be used to analyze the differences between the different 
measurement instruments at baseline and after implementa-
tion of the COPDnet model. To evaluate the potential health 
status benefits by testing the differences between baseline 
PROMS and follow-up PROMS, a two-tailed paired sample 
t-test or the Wilcoxon signed rank test will also be used. A 
priori, a two-sided level of significance will be set at p#0.05. 
For data analysis, SPSS V.22.0 will be used.
The economic evaluation of the cost of care of the 
COPDnet model, based on the different TDABC models, 
will be analyzed with appropriate descriptive statistics and 
will be displayed graphically.
Qualitative analyses
To evaluate the feasibility and the costs of care, all semi-
structured interviews of the COPDnet model will be 
audio-taped after obtaining the respondent’s permission. 
Subsequently, the audio tapes will be transcribed verbatim 
and entered into Atlas.ti qualitative software for analysis. 
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We will use qualitative content analysis with a directed 
approach.29 We will conduct a thematic analysis of the 
implementation of the COPDnet model. Results from the 
qualitative analyses will be triangulated with results from 
the quantitative analyses to identify concordant and disparate 
results across the data sources. 
Ethics and dissemination
The Research Ethics Committee of the Radboud University 
Medical Center has passed a positive judgment on the study. 
The Committee considered that the study protocol does not 
fall within the remit of the Medical Research Involving 
Human Subjects Act (WMO) (ref: 2017/3597). Patients, 
health care professionals, and organizational managers will 
be asked to sign an Informed Consent form before partici-
pating in a semi-structured interview. This project will be 
conducted according to the Declaration of Helsinki and the 
Agreement on Medical Treatment Act (In Dutch: Wet op de 
Geneeskundige Behandelingsovereenkomst or WGBO). 
Discussion
This study protocol focuses on the challenge to implement 
the COPDnet integrated care model into three hospitals and 
affiliated primary care regions. It will evaluate the feasibility 
of integrating the COPDnet model into actual care within the 
context of the Dutch health care system. It will evaluate the 
potential health status benefits from the patient’s perspec-
tive, and it will evaluate the direct and indirect costs, on the 
basis of TDABC models, of the diagnostic trajectory as a 
component of the COPDnet model. This study protocol has 
strengths and limitations, which will be discussed below.
Strengths
A major strength of this study protocol is that we evaluate 
Dutch real-life care, derived from the care delivered by the 
implemented COPDnet integrated care models. Although 
the number of real-life studies on COPD is growing,30 little 
scientific data are available on the outcome of real-life COPD 
care outside the remit of treatment or exacerbations.31 The 
first publications on the outcome of this real-life COPD care 
suggest room for improvement on the organization of care, 
the content of care, and the cost-effectiveness of care.9,32–35
This study will generate knowledge about the COPDnet 
model, which is founded on the principles of the CCM. 
The aim of the CCM is to transform daily care for patients 
with chronic illnesses from acute and reactive, to proactive, 
planned, and population-based.36 The use of the principles 
of the CCM in the context of COPD holds the promise to 
generate better outcomes of care.11
Furthermore, this study protocol describes a multisite 
study. The COPDnet model will be implemented in three 
hospitals, each with a different character, and, subsequently, 
in different allied primary care regions. Although the 
COPDnet integrated care model was designed for the Dutch 
health care system, it is deemed applicable, mutatis mutandis, 
in every country that sets out to apply an integrated approach 
in an integrated health care chain. We based the development 
of the COPDnet model on evidence and frameworks avail-
able in the international literature. We think that our model 
is applicable in other health care systems, when tailored to 
national and local context.
Finally, this study protocol will provide a multiperspec-
tive evaluation of the COPDnet model. Our COPDnet model 
is an integrated care model, and its evaluation is an integral 
part of it. Our analysis will focus on patient perspective, 
health care professional perspective, and organizational 
perspective in primary and secondary care settings. 
limitations
This study protocol has two limitations. First, this study 
protocol lacks a controlled design. This means that we have 
to be careful with the conclusions we draw from our study 
and we can apply the recommendations only to the local geo-
graphic context of our three COPDnet hospitals and primary 
care regions. However, randomized controlled trials may 
have a high internal validity, whereas real-life studies have 
high generalizability.30 Nevertheless, we consider the current 
study as a proof of concept of the deployment of the COPDnet 
model, that is of the feasibility of working with the model, 
rather than a study on its effectiveness. Second, we have 
developed the current COPDnet model as it stands, but we 
are aware of its fragility. After the diagnostic trajectory in a 
secondary care setting, patients may be referred for further 
guidance and intervention to either a primary care setting or a 
form of pulmonary rehabilitation in secondary or tertiary care 
settings. Referrals are based on the assessment of the burden 
of disease and actual individual traits. For this purpose, guide-
lines on decision making were developed. Even so, uptake, 
completion, and quality of the delivered intervention(s) can 
only be partly controlled for. As a result, changes in health 
status over time may be difficult to interpret.
Clinical consequences
This study protocol will provide prime insights with respect 
to feasibility, health status benefits, and cost of care of the 
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diagnostic trajectory of the COPDnet integrated care model 
in three hospitals and their affiliated primary care regions. 
It is anticipated that adjustments of the current model are to 
be made. Subsequently, a follow-up study may be performed 
with a controlled design to evaluate the clinical (cost)-
effectiveness of the model.
Conclusion
The COPDnet integrated care model for patients with COPD 
has been designed according to current insights regarding 
effective care for patients with a chronic condition in general 
and for patients with COPD in particular. It will be evaluated 
for its feasibility, potential health status benefits, and the costs 
of care of the diagnostic trajectory in secondary care.
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